These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1409785)

  • 1. [Leu]enkephalin and its metabolite, Tyr-Gly-Gly, impair active avoidance retention.
    Schulteis G; Martinez JL
    Pharmacol Biochem Behav; 1992 Jul; 42(3):523-7. PubMed ID: 1409785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Only tyrosine-containing metabolites of [Leu]enkephalin impair active avoidance conditioning in mice.
    Janak PH; Martinez JL
    Pharmacol Biochem Behav; 1990 Dec; 37(4):655-9. PubMed ID: 2093169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects on active avoidance performance and locomotor activity of two major enkephalin metabolites, tyr-gly-gly and des-tyr-[leu]enkephalin.
    Weinberger SB; Martinez JL
    Life Sci; 1988; 43(9):769-76. PubMed ID: 3412113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Leu]enkephalin enhances active avoidance conditioning in rats and mice.
    Janak PH; Manly JJ; Martinez JL
    Neuropsychopharmacology; 1994 Feb; 10(1):53-60. PubMed ID: 8179794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience-dependent regulation of Leu-enkephalin hydrolysis in rat plasma.
    Schulteis G; Martinez JL
    Peptides; 1993; 14(2):161-7. PubMed ID: 8483796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptors for opioid peptides in the guinea-pig ileum.
    Takemori AE; Portoghese PS
    J Pharmacol Exp Ther; 1985 Nov; 235(2):389-92. PubMed ID: 2997432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leu-enkephalin actions on avoidance conditioning are mediated by a peripheral opioid mechanism.
    Martinez JL; de Graaf JS; Chavkin C; Dana RC
    Life Sci; 1985 Dec; 37(25):2345-53. PubMed ID: 3001460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of vagotomy on Leu-enkephalin-induced changes in memory storage processes.
    Williams CL; Jensen RA
    Physiol Behav; 1993 Oct; 54(4):659-63. PubMed ID: 8248342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of peptidase inhibitors on the apparent agonist potency of delta selective opioid peptides in vitro.
    Kramer TH; Toth G; Haaseth RC; Matsunaga TO; Davis P; Hruby VJ; Burks TF
    Life Sci; 1991; 48(9):881-6. PubMed ID: 1847736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leu-enkephalin impairs memory of an appetitive maze response in mice.
    Linden D; Martinez JL
    Behav Neurosci; 1986 Feb; 100(1):33-8. PubMed ID: 3513799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose- and strain-dependent effects of dermorphin and [D-Ala2-D-Leu5]enkephalin on passive avoidance behavior in mice.
    Castellano C; Pavone F
    Behav Neurosci; 1985 Dec; 99(6):1120-7. PubMed ID: 2886135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enkephalin actions on avoidance conditioning may be related to adrenal medullary function.
    Martinez JL; Rigter H
    Behav Brain Res; 1982 Nov; 6(3):289-99. PubMed ID: 7171387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of leucine-enkephalin on active avoidance responding in mice.
    Dana RC; Martinez JL
    Behav Neurosci; 1986 Apr; 100(2):185-9. PubMed ID: 3964420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DPen2-[DPen5]enkephalin, a delta opioid receptor-selective analog of [Leu]enkephalin, impairs avoidance learning in an automated shelf-jump task in rats.
    Weinberger SB; Gehrig CA; Martinez JL
    Regul Pept; 1989 Dec; 26(3):323-9. PubMed ID: 2623195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of concanavalin A-induced, antigen-nonspecific regulatory cell activity by leu-enkephalin and related peptides.
    Sizemore RC; Dienglewicz RL; Pecunia E; Gottlieb AA
    Clin Immunol Immunopathol; 1991 Aug; 60(2):310-8. PubMed ID: 1676942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of endogenous cholecystokinin in the facilitation of mu-mediated antinociception by delta-opioid agonists.
    Noble F; Smadja C; Roques BP
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1127-34. PubMed ID: 7996417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
    Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
    Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary metabolism of exogenous enkephalins in isolated perfused rat lungs.
    Gillespie MN; Krechniak JW; Crooks PA; Altiere RJ; Olson JW
    J Pharmacol Exp Ther; 1985 Mar; 232(3):675-81. PubMed ID: 2983067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central delta-opioid receptor interactions and the inhibition of reflex urinary bladder contractions in the rat.
    Dray A; Nunan L; Wire W
    Br J Pharmacol; 1985 Jul; 85(3):717-26. PubMed ID: 2992671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replacement of the peptide-backbone amides connecting Tyr-Gly and Gly-Gly in leucine-enkephalin with ketomethylene groups: synthesis and biological activity.
    Almquist RG; Olsen CM; Uyeno ET; Toll L
    J Med Chem; 1984 Feb; 27(2):115-20. PubMed ID: 6319699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.